Clinical trial
Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow…
NCT00317876 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00317876 |
|---|---|
| Title | Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia |
| Official title | Dose-Finding Study for Cyclophosphamide as Conditioning Regimens for Bone Marrow Transplantation From Related Donors in Patients With Fanconi Anemia |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fanconi Anemia |
| Intervention type | Drug, Procedure |
| Interventions | cyclophosphamide, cyclosporine, methotrexate, allogeneic bone marrow transplantation, nonmyeloablative allogeneic hematopoietic stem cell transplantation |
| Enrollment | 25 |
| Start date | Jun 1, 1998 |
| Primary completion | Jul 1, 2003 |
| First posted | Apr 25, 2006 |
| Last update posted | Apr 20, 2012 |
| Countries | Brazil, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: